Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.57 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.57 |
| ▸ | PGR | P06401 | 1/20 | 0.57 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.51 |
| ▸ | F7 | P08709 | 3/20 | 0.51 |
| ▸ | F3 | P13726 | 3/20 | 0.51 |
| ▸ | PPARG | P37231 | 3/20 | 0.51 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | PPARD | Q03181 | 2/20 | 0.51 |
| ▸ | PPARA | Q07869 | 2/20 | 0.51 |
| ▸ | RXRA | P19793 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13468282 | 0.97 | ADORA3 (0.53) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL18471979 | 0.91 | ALDH1A1 (0.49) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL18471980 | 0.89 | ADORA3 (0.49) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL17212394 | 0.88 | ALDH1A1 (0.49) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL17212642 | 0.84 | ALDH1A1 (0.51) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL29466470 | 0.84 | ALDH1A1 (0.51) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL18487106 | 0.83 | ALDH1A1 (0.44) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL18471974 | 0.83 | ALDH1A1 (0.44) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL2519158 | 0.82 | ALDH1A1 (0.52) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL2518096 | 0.82 | ALDH1A1 (0.52) | ADORA3NR1I2PTGS2PGRPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11014947-B2 | Lipophenol compounds and uses thereof | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2021-05-25 | — | — | US | disclosed |
| US-10011620-B2 | Lipophenol compounds and uses thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2018-07-03 | — | — | US | disclosed |
| US-10011620-B2 | Lipophenol compounds and uses thereof | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2018-07-03 | — | — | US | disclosed |
| US-20170037067-A1 | NEW LIPOPHENOL COMPOUNDS AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2017-02-09 | — | — | US | disclosed |
| US-20170037067-A1 | NEW LIPOPHENOL COMPOUNDS AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2017-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11014947-B2 | Lipophenol compounds and uses thereof | LPO, CBR1, LCLAT1 | ADORA3 2717/4885NR1I2 896/4885PTGS2 1294/4885 |
| US-20170037067-A1 | NEW LIPOPHENOL COMPOUNDS AND USES THEREOF | LCLAT1, CBR1, LPO | ADORA3 2736/4885NR1I2 720/4885PTGS2 1650/4885 |
| US-10011620-B2 | Lipophenol compounds and uses thereof | LPO, CBR1, LCLAT1 | ADORA3 2717/4885NR1I2 896/4885PTGS2 1294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.